Related Experiment Videos
Bone marrow stem cells do not repopulate the healthy upper respiratory tract.
Jane C Davies1, Mike Potter, Andrew Bush
1Department of Gene Therapy, Imperial College at the National Heart and Lung Institute, London, UK. j.c.davies@ic.ac.uk
Pediatric Pulmonology
|September 3, 2002
Summary
Bone marrow stem cells do not differentiate into nasal respiratory epithelium. This finding suggests whole bone marrow transplantation is unlikely to correct cystic fibrosis (CF) airways.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Respiratory medicine
Background:
- Recent studies suggest stem cells can differentiate into various cell types, offering potential therapeutic avenues.
- Bone marrow stem cells differentiating into hepatocytes and lung epithelium have been reported, raising hope for liver and respiratory diseases like cystic fibrosis (CF).
Purpose of the Study:
- To investigate whether bone marrow progenitor cells can differentiate into respiratory epithelial cells in the human upper airway.
- To assess the potential of bone marrow transplantation as a therapeutic strategy for correcting the respiratory epithelium in conditions like CF.
Main Methods:
- Examined nasal epithelium samples from 6 female patients who received gender-mismatched bone marrow transplants up to 15 years prior.
- Utilized Y-chromosome fluorescence in situ hybridization to identify donor-derived cells and anti-cytokeratin antibodies to confirm epithelial cell lineage.
Main Results:
- Donor-derived (male) nuclei were detected in nasal epithelium samples, ranging from 0.7% to 18.1%.
- However, these donor-derived cells lacked anti-cytokeratin antibody staining, indicating they were not epithelial cells but likely lymphocytes or mesenchymal cells.
- Confirmed absence of bone marrow progenitor cell differentiation into healthy upper airway respiratory epithelium.
Conclusions:
- Whole bone marrow transplantation does not lead to the differentiation of bone marrow progenitor cells into respiratory epithelium in the healthy human upper airway.
- The lack of differentiation suggests that whole bone marrow transplantation is unlikely to be a viable approach for correcting the cystic fibrosis airway defect.
- Discrepancies with other studies may be due to differences in transplanted cells, cell turnover rates, or the need for specific differentiation-inducing triggers.